| Literature DB >> 31936295 |
Ahmad Alsaber1, Jiazhu Pan1, Adeeba Al-Herz2, Dhary S Alkandary3, Adeeba Al-Hurban3, Parul Setiya4.
Abstract
Rheumatoid arthritis (RA) is a chronic autoimmune of an unknown etiology. Air pollution has been proposed as one of the possible risk factors associated with disease activity, although has not been extensively studied. In this study, we measured the relationship between exposure to air pollutants and RA activity. Data on RA patients were extracted from the Kuwait Registry for Rheumatic Diseases (KRRD). Disease activity was measured using disease activity score with 28 examined joints (DAS-28) and the Clinical Disease Activity Index (CDAI) during their hospital visits from 2013 to 2017. Air pollution was assessed using air pollution components (PM 10 , NO 2 , SO 2 , O 3 , and CO). Air pollution data were obtained from Kuwait Environmental Public Authority (K-EPA) from six different air quality-monitoring stations during the same period. Multiple imputations by the chained equations (MICE) algorithm were applied to estimate missing air pollution data. Patients data were linked with air pollution data according to date and patient governorate address. Descriptive statistics, correlation analysis, and linear regression techniques were employed using STATA software. In total, 1651 RA patients with 9875 follow-up visits were studied. We detected an increased risk of RA using DAS-28 in participants exposed to SO 2 and NO 2 with β = 0 . 003 (95% CI: 0.0004-0.005, p < 0 . 01 ) and β = 0 . 003 (95% CI: 0.002-0.005, p < 0 . 01 ), respectively, but not to PM 10 , O 3 , and CO concentrations. Conclusively, we observed a strong association between air pollution with RA disease activity. This study suggests air pollution as a risk factor for RA and recommends further measures to be taken by the authorities to control this health problem.Entities:
Keywords: AQI; CDAI; DAS-28; KRRD; Kuwait; Middle East; RA registry; air pollution; rheumatoid arthritis
Mesh:
Year: 2020 PMID: 31936295 PMCID: PMC7013841 DOI: 10.3390/ijerph17020416
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Kuwait Air Quality Index. PM: particulate matter with aerodynamic diameter ≤10 m.
| Categories | AQI, | O | PM | CO (ppm), | SO | NO |
|---|---|---|---|---|---|---|
| Good | 0–50 | 0.0–0.03 | 0.0–90 | 0.0–4.0 | 0.0–0.03 | 0.0–0.03 |
| Moderate | 51–100 | 0.031–0.06 | 90.1–350.0 | 4.1–8.0 | 0.031–0.06 | 0.04–0.05 |
| Unhealthy (1) | 101–150 | 0.061–0.092 | 350.1–431.1 | 8.1–11.7 | 0.061–0.182 | 0.06–0.30 |
| Unhealthy (2) | 151–200 | 0.093–0.124 | 431.4–512.5 | 11.8–15.4 | 0.183–0.304 | 0.31–0.55 |
| Very Unhealthy | 201–300 | 0.125–0.374 | 512.6–675.0 | 15.5–30.4 | 0.305–0.604 | 0.56–1.04 |
| Hazardous | 301–500 | 0.375–0.504 | 675.1–1000 | 30.5–50.4 | 0.605–1.004 | 1.05–2.04 |
Figure 1Matching Procedures to combine Air Quality Index (AQI) information with Kuwait Registry for Rheumatic Diseases (KRRD) patient profile records using date and governorate address information). K-EAPL, Environmental Public Authority of Kuwait; RA, rheumatoid arthritis.
RA patient visit demographic and clinical features groups by governorate—2012 to 2017.
| [ALL] | Ahmadi | Farwaniya | Hawally | Jahra | Kuwait City | Mubarak | |
|---|---|---|---|---|---|---|---|
| Gender: | |||||||
| male | 3867 (39.2%) | 73 (20.5%) | 2656 (60.7%) | 285 (22.4%) | 82 (36.3%) | 653 (21.7%) | 118 (18.6%) |
| female | 6008 (60.8%) | 283 (79.5%) | 1722 (39.3%) | 987 (77.6%) | 144 (63.7%) | 2354 (78.3%) | 518 (81.4%) |
| Nationality: | |||||||
| Kuwaitis | 5783 (58.6%) | 328 (92.1%) | 1499 (34.2%) | 773 (60.8%) | 145 (64.2%) | 2462 (81.9%) | 576 (90.6%) |
| non-Kuwaitis | 4092 (41.4%) | 28 (7.87%) | 2879 (65.8%) | 499 (39.2%) | 81 (35.8%) | 545 (18.1%) | 60 (9.43%) |
| Visited Hospital: | |||||||
| Amiri | 5051 (51.1%) | 294 (82.6%) | 364 (8.31%) | 774 (60.8%) | 120 (53.1%) | 2955 (98.3%) | 544 (85.5%) |
| Farwaniya | 3981 (40.3%) | 0 (0.00%) | 3976 (90.8%) | 5 (0.39%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) |
| Jahra | 111 (1.12%) | 0 (0.00%) | 2 (0.05%) | 3 (0.24%) | 106 (46.9%) | 0 (0.00%) | 0 (0.00%) |
| Mubarak | 732 (7.41%) | 62 (17.4%) | 36 (0.82%) | 490 (38.5%) | 0 (0.00%) | 52 (1.73%) | 92 (14.5%) |
| Disease Duration | 9.82 (6.48) | 13.3 (9.11) | 9.39 (5.79) | 10.4 (7.03) | 10.2 (6.45) | 9.42 (5.78) | 11.4 (9.60) |
| Comorbidity | |||||||
| Yes | 5393 (54.6%) | 226 (63.5%) | 1658 (37.9%) | 802 (63.1%) | 123 (54.4%) | 2157 (71.7%) | 427 (67.1%) |
| No | 4482 (45.4%) | 130 (36.5%) | 2720 (62.1%) | 470 (36.9%) | 103 (45.6%) | 850 (28.3%) | 209 (32.9%) |
| Treatment Class: | |||||||
| Biologics | 5214 (52.8%) | 327 (91.9%) | 1342 (30.7%) | 762 (59.9%) | 131 (58.0%) | 2124 (70.6%) | 528 (83.0%) |
| cDMARDs | 4661 (47.2%) | 29 (8.15%) | 3036 (69.3%) | 510 (40.1%) | 95 (42.0%) | 883 (29.4%) | 108 (17.0%) |
| RF | |||||||
| Positive | 6881 (74.6%) | 235 (72.8%) | 3148 (76.3%) | 817 (71.0%) | 177 (93.2%) | 2042 (72.0%) | 462 (76.5%) |
| Negative | 2348 (25.4%) | 88 (27.2%) | 976 (23.7%) | 334 (29.0%) | 13 (6.84%) | 795 (28.0%) | 142 (23.5%) |
| ACPA: | |||||||
| Positive | 4934 (60.5%) | 102 (33.6%) | 2665 (70.3%) | 593 (63.1%) | 73 (61.3%) | 1205 (48.1%) | 296 (60.0%) |
| Negative | 3216 (39.5%) | 202 (66.4%) | 1125 (29.7%) | 347 (36.9%) | 46 (38.7%) | 1299 (51.9%) | 197 (40.0%) |
| Patient GA | 1.64 (2.36) | 1.54 (2.34) | 1.02 (1.85) | 2.60 (2.69) | 2.09 (2.52) | 1.95 (2.56) | 2.39 (2.69) |
| Physician GA | 1.05 (1.77) | 1.06 (1.82) | 0.72 (1.50) | 1.63 (2.02) | 1.58 (2.21) | 1.13 (1.78) | 1.64 (2.18) |
| DAS-28 | 2.67 (1.26) | 1.85 (1.35) | 2.70 (1.21) | 2.77 (1.29) | 3.04 (1.39) | 2.61 (1.22) | 2.79 (1.44) |
| CDAI | 6.24 (9.96) | 4.64 (8.89) | 4.83 (8.56) | 8.31(10.72) | 9.45 (14.25) | 6.78 (10.49) | 9.00 (11.53) |
| ESR | 27.19 (21.79) | 15.12 (16.82) | 30.24 (23.10) | 26.77 (20.30) | 30.06 (19.33) | 23.97 (19.54) | 27.80 (24.04) |
| CRP | 6.32 (4.85) | 4.32 (3.91) | 7.29 (4.89) | 4.53 (4.53) | 6.36 (4.42) | 6.08 (4.68) | 5.38 (4.87) |
| Swollen Joints | 0.69 (2.26) | 0.34 (1.57) | 1.08 (2.60) | 0.53 (1.97) | 0.95 (3.63) | 0.26 (1.67) | 0.57 (1.99) |
| Tender Joints | 2.87 (5.60) | 1.72 (4.32) | 2.02 (4.18) | 3.55 (6.21) | 4.82 (8.39) | 3.46 (6.36) | 4.54 (7.13) |
RF, rheumatoid factor; ACPA, anti-cyclic citrullinated peptide antibody. Comorbidity (e.g., hypertension, hyperlipidemia, diabetes mellitus, etc.); Disease Duration, RA disease duration by years. DMARDs, conventional disease modifying anti-rheumatic drugs. GA, global assessment.
Distribution of Kuwait ambient air pollution exposure using AQI during 2012–2017.
| Air Pollutant | Ahmadi (n = 356) | Farwaniya (n = 4378) | Hawally (n = 1272) | Jahra (n = 226) | Kuwait City (n = 3007) | Mubarak Alkabeer (n = 636) | ALL (n = 9875) |
|---|---|---|---|---|---|---|---|
| min | 17.108 | 20.346 | 21.948 | 18.837 | 12.138 | 5.421 | 5.421 |
| 25th | 75.839 | 76.312 | 80.692 | 67.417 | 71.114 | 74.886 | 74.965 |
| median | 112.623 | 120.779 | 113.586 | 92.788 | 116.081 | 109.917 | 113.586 |
| 75th | 180.403 | 186.145 | 180.581 | 151.762 | 193.121 | 184.282 | 186.568 |
| max | 549.419 | 511.826 | 588.494 | 545.789 | 577.706 | 585.077 | 588.494 |
| mean (SD | 142.36 ± 99.58 | 146.47 ± 94.20 | 145.69 ± 99.23 | 123.64 ± 95.00 | 146.81 ± 102.42 | 142.40 ± 102.79 | 144.87 ± 100.64 |
| min | 0.240 | 0.207 | 0.087 | 0.042 | 0.087 | 0.292 | 0.042 |
| 25th | 0.938 | 0.945 | 0.984 | 0.854 | 1.006 | 0.978 | 0.975 |
| median | 1.367 | 1.338 | 1.337 | 1.151 | 1.369 | 1.380 | 1.346 |
| 75th | 1.679 | 1.603 | 1.672 | 1.455 | 1.679 | 1.728 | 1.672 |
| max | 4.894 | 4.701 | 4.471 | 5.122 | 8.143 | 5.287 | 8.143 |
| mean (SD) | 1.37 ± 0.62 | 1.33 ± 0.57 | 1.40 ± 0.66 | 1.14 ± 0.64 | 1.40 ± 0.66 | 1.46 ± 0.70 | 1.39 ± 0.66 |
| min | 9.080 | 9.080 | 5.346 | 8.229 | 5.346 | 5.346 | 5.346 |
| 25th | 25.768 | 28.200 | 27.208 | 29.127 | 27.319 | 32.037 | 27.391 |
| median | 35.762 | 36.537 | 35.810 | 52.420 | 36.795 | 44.744 | 37.355 |
| 75th | 54.218 | 53.150 | 51.409 | 67.866 | 52.054 | 68.210 | 54.552 |
| max | 137.960 | 135.878 | 134.123 | 107.279 | 208.670 | 207.557 | 208.670 |
| mean (SD) | 42.85 ± 24.13 | 42.01 ± 20.70 | 41.29 ± 20.60 | 50.92 ± 25.54 | 43.00 ± 22.76 | 52.09 ± 27.91 | 43.74 ± 23.13 |
| min | 4.051 | 4.051 | 4.051 | 5.887 | 3.476 | 4.877 | 3.476 |
| 25th | 10.965 | 11.030 | 10.851 | 12.457 | 10.581 | 11.328 | 10.851 |
| median | 15.215 | 15.372 | 15.104 | 18.192 | 14.709 | 14.164 | 14.985 |
| 75th | 20.874 | 22.240 | 20.451 | 25.172 | 20.451 | 19.507 | 20.759 |
| max | 54.262 | 69.682 | 80.656 | 37.539 | 88.623 | 57.330 | 88.623 |
| mean (SD) | 17.04 ± 8.75 | 18.53 ± 11.27 | 17.58 ± 10.52 | 18.71 ± 7.24 | 16.85 ± 10.08 | 16.26 ± 7.51 | 17.19 ± 9.90 |
| min | 0.003 | 1.000 | 1.000 | 0.665 | 0.003 | 1.000 | 0.003 |
| 25th | 4.208 | 5.293 | 4.875 | 5.435 | 4.490 | 7.333 | 4.875 |
| median | 8.333 | 8.000 | 8.594 | 13.792 | 7.993 | 14.083 | 8.727 |
| 75th | 14.146 | 17.292 | 17.169 | 24.583 | 16.746 | 22.946 | 17.504 |
| max | 121.833 | 121.833 | 121.833 | 76.875 | 111.917 | 127.875 | 127.875 |
| mean (SD) | 13.15 ± 15.46 | 13.26 ± 14.22 | 14.18 ± 16.10 | 17.90 ± 16.52 | 13.39 ± 14.60 | 18.62 ± 17.07 | 14.26 ± 15.42 |
1 25th, lower quartile (25th percentile). 2 75th, upper quartile (75th percentile). 3 SD: standard deviation.
Figure 2Air quality index (AQI) ambients for six governorate monitoring stations in Kuwait from 2013 to 2017.
Correlation analysis between rheumatoid arthritis disease factors and AQI for SO, NO, CO, O, and PM.
| DAS-28 | CDAI | NO | O | SO | CO | PM | Swollen | Tender | ESR | |
|---|---|---|---|---|---|---|---|---|---|---|
| DAS-28 | ||||||||||
| CDAI | 0.77 **** | |||||||||
| NO | 0.07 **** | 0.11 **** | ||||||||
| O | 0.00 | 0.00 | −0.12 **** | |||||||
| SO | 0.07 **** | 0.10 **** | 0.51 **** | −0.09 **** | ||||||
| CO | −0.01 | 0.02 | 0.22 **** | 0.02 | 0.07 **** | |||||
| PM | 0.00 | −0.02 | −0.12 **** | 0.08 **** | −0.03 * | −0.05 ** | ||||
| Swollen | 0.50 **** | 0.60 **** | 0.01 | 0.01 | 0.01 | 0.00 | −0.02 | |||
| Tender | 0.72 **** | 0.93 **** | 0.13 **** | 0.01 | 0.11 **** | 0.03 | −0.01 | 0.42 **** | ||
| ESR | 0.65 **** | 0.20 **** | 0.00 | −0.02 | 0.04 * | −0.04 * | 0.02 | 0.16 **** | 0.17 **** | |
| CRP | 0.28 **** | 0.02 * | 0.01 | 0.02 | 0.01 | −0.01 | −0.01 | 0.11 **** | 0.02 * | 0.37 **** |
Note: * p < 0.1; ** p < 0.05; *** p < 0.01; **** p < 0.001.
Coefficients estimated by hierarchal linear model (HLM) for DAS-28 (standard error in parentheses).
| Dependent Variable | ||||
|---|---|---|---|---|
| DAS-28 | ||||
| (M1) | (M2) | (M3) | (M4) | |
| Gender (male) | −0.213 *** | −0.040 *** | ||
| (−0.268, −0.157) | (−0.064, −0.017) | |||
| RA Disease Duration | −0.002 | −0.004 *** | ||
| (−0.006, 0.002) | (−0.006, −0.003) | |||
| Nationality (non-Kuwaitis) | 0.272 *** | 0.022 | ||
| (0.214, 0.331) | (−0.007, 0.051) | |||
| Governorate (Farwaniya) | 0.807 *** | 0.299 *** | ||
| (0.666, 0.947) | (0.239, 0.358) | |||
| Governorate (Hawally) | 0.852 *** | 0.277 *** | ||
| (0.704, 1.000) | (0.214, 0.341) | |||
| Governorate (Jahra) | 1.143 *** | 0.254 *** | ||
| (0.933, 1.352) | (0.150, 0.359) | |||
| Governorate (Kuwait City) | 0.744 *** | 0.290 *** | ||
| (0.606, 0.882) | (0.232, 0.348) | |||
| Governorate (Mubarak Alkabeer) | 0.955 *** | 0.175 *** | ||
| (0.793, 1.117) | (0.106, 0.244) | |||
| Comorbidity (Yes) | 0.060 ** | −0.051 *** | ||
| (0.007, 0.114) | (−0.074, −0.029) | |||
| Treatment Class (cDMARDs) | 0.064 *** | |||
| (0.036, 0.092) | ||||
| Swollen | 0.090 *** | 0.226 *** | ||
| (0.085, 0.095) | (0.208, 0.244) | |||
| Tender | 0.099 *** | |||
| (0.096, 0.101) | ||||
| RF (Positive) | 0.035 *** | 0.004 | ||
| (0.010, 0.060) | (−0.078, 0.085) | |||
| ACPA (Positive) | 0.008 | 0.007 | ||
| (−0.015, 0.031) | (−0.063, 0.078) | |||
| Patient Global Assessment | 0.097 *** | |||
| (0.088, 0.105) | ||||
| Physician Global Assessment | 0.014 ** | |||
| (0.002, 0.025) | ||||
| ESR | 0.028 *** | 0.035 *** | ||
| (0.027, 0.028) | (0.034, 0.037) | |||
| CRP | 0.017 *** | 0.001 | ||
| (0.015, 0.020) | (−0.006, 0.009) | |||
| NO | 0.003 ** | 0.003 *** | ||
| (0.001, 0.005) | (0.002, 0.005) | |||
| O | 0.002 | 0.003 | ||
| (−0.002, 0.006) | (−0.001, 0.006) | |||
| SO | 0.004 *** | 0.003 ** | ||
| (0.001, 0.007) | (0.0004, 0.005) | |||
| CO | −0.051 | −0.001 | ||
| (−0.114, 0.012) | (−0.053, 0.052) | |||
| PM | 0.0002 | 0.00003 | ||
| (−0.0002, 0.001) | (−0.0003, 0.0004) | |||
| Constant | 1.845 *** | 1.029 *** | 2.586 *** | 1.506 *** |
| (1.701, 1.988) | (0.966, 1.093) | (2.435, 2.738) | (1.358, 1.654) | |
| R | 0.034 | 0.865 | 0.007 | 0.488 |
| Adjusted R | 0.033 | 0.865 | 0.006 | 0.486 |
Note: ** p < 0.05; *** p < 0.01.
Coefficients estimated through HLM for CDAI (standard error in parentheses).
| Dependent Variable | ||||
|---|---|---|---|---|
| CDAI | ||||
| (M1) | (M2) | (M3) | (M4) | |
| Gender (male) | −0.748 *** | −0.078 | ||
| (−1.187, −0.309) | (−0.218, 0.061) | |||
| RA Disease Duration | −0.052 *** | 0.005 | ||
| (−0.082, −0.021) | (−0.005, 0.015) | |||
| Nationality (non-Kuwaitis) | 1.209 *** | 0.255 *** | ||
| (0.747, 1.671) | (0.081, 0.429) | |||
| Governorate (Farwaniya) | 0.066 | −1.199 *** | ||
| (−1.044, 1.176) | (−1.550, −0.848) | |||
| Governorate (Hawally) | 3.408 *** | 0.526 *** | ||
| (2.241, 4.576) | (0.152, 0.900) | |||
| Governorate (Jahra) | 4.662 *** | −0.559 * | ||
| (3.008, 6.315) | (−1.179, 0.062) | |||
| Governorate (Kuwait City) | 1.947 *** | −0.135 | ||
| (0.858, 3.036) | (−0.476, 0.207) | |||
| Governorate (Mubarak Alkabeer) | 4.430 *** | −0.064 | ||
| (3.150, 5.709) | (−0.474, 0.345) | |||
| Comorbidity (Yes) | 0.984 *** | 0.147 ** | ||
| (0.564, 1.405) | (0.014, 0.281) | |||
| Treatment Class (cDMARDs) | −0.059 | |||
| (−0.225, 0.107) | ||||
| Swollen | 1.145 *** | 3.035 *** | ||
| (1.114, 1.175) | (2.848, 3.222) | |||
| Tender | 1.423 *** | |||
| (1.410, 1.435) | ||||
| RF (Positive) | 0.025 | −0.066 | ||
| (−0.123, 0.173) | (−0.901, 0.770) | |||
| ACPA (Positive) | 0.226 *** | −0.594 | ||
| (0.090, 0.363) | (−1.320, 0.132) | |||
| Patient Global Assessment | 1.067 *** | |||
| (1.059, 1.075) | ||||
| Physician Global Assessment | 0.871 *** | |||
| (0.861, 0.881) | ||||
| ESR | 0.019 *** | 0.085 *** | ||
| (0.016, 0.022) | (0.068, 0.103) | |||
| CRP | −0.050 *** | −0.171 *** | ||
| (−0.064, −0.037) | (−0.246, −0.095) | |||
| NO | 0.040 *** | 0.048 *** | ||
| (0.022, 0.058) | (0.030, 0.066) | |||
| O | 0.027 | 0.039 ** | ||
| (−0.008, 0.062) | (0.003, 0.074) | |||
| SO | 0.044 *** | 0.044 *** | ||
| (0.018, 0.070) | (0.018, 0.070) | |||
| CO | −0.062 | 0.185 | ||
| (−0.601, 0.476) | (−0.358, 0.729) | |||
| PM | 0.001 | 0.0004 | ||
| (−0.003, 0.004) | (−0.003, 0.004) | |||
| Constant | 4.537 *** | 1.322 *** | 5.306 *** | 2.540 *** |
| (3.404, 5.671) | (0.948, 1.697) | (4.006, 6.606) | (1.017, 4.064) | |
| R | 0.030 | 0.925 | 0.015 | 0.299 |
| Adjusted R | 0.029 | 0.925 | 0.014 | 0.297 |
Note: * p < 0.1; ** p < 0.05; *** p < 0.01.